Path Exam 2- GI disease & lymphomas Flashcards
(42 cards)
Cholera
- sites: SI
- symptoms: severe watery diarrhea “rice water”
- complications: dehydration, electrolyte imbalances
A subunits catalyzes ADP-ribosylation of GTP-binding proteins causing persistant activation of adeylate cyclase wwhich increases cAMP and Cl- secretion
Campylobacter spp.
- sites: colon
- symptoms: watery or bloody diarrhea
- complications: Guillain-Barre, arthritis
- -looks like UC
Shiegellosis
- sites: left colon, Ileum
- symptoms: bloody diarrhea
- complications: Reiter syndrome, HUS
- looks like UC
Salmonellosis
- sites: colon and SI
- symptoms: watery or bloody diarrhea
- complications: sepsis, abscess
- looks like UC
Enteric (typhoid) fever
- sites: SI
- symptoms: bloody diarrhea, fever
- complications: chronic infection, carrier state, encephalopathy, myocarditis; *perforation
Fecal mononuclear leukocytes
Yersinia spp.
- sites: ileum, appendix, right colon
- symptoms: abdominal pain, fever, diarrhea
- complications: Autoimmune e.g. reiter syndrome of reactive arthritis
E. coli (EnteroToxigenicEC)
- sites: SI
- symptoms: severe watery diarrhea
- complications: dehydration, electrolyte imbalance
Enterohemorrhagic (EHEC)
- sites: colon
- symptoms: bloody diarrhea
- complications: HUS
Pseudomembranous Colitis
C. difficile
- sites: colon
- symptoms: watery diarrhea, fever
- complications: relapse, toxic megacolon, mushroom cloud/ volcanic erruption
Whipple disease
- sites: SI
- symptoms: diarrhea/malabsorption (lymphatic transport)
- complications: arthritis*, CNS dis, PAS + macrophages in lamina propria
-male farmers 30-50yrs
-symptoms may last YEARS
Tropheryma whippelii
Follicular lymphoma
- B cell
- Indolent; median survival 7 yrs
- CD 20, 19, 10
- t(14:18) overexpress BCL2 (blocks apoptosis, chemo res.)
- nodal
- follicles that are BCL2 +
- adults; middle yrs
- poor response to chemo, can transform into large B cell
Large B cell lymphoma
- B cell
- Aggressive; months, good response to chemo
- CD 19, 20
- BCL6 (↑ growth ↓ differentiation ↓ apoptosis)
- often extranodal: CNS in HIV, Waldeyer ring (destructive mass in liver or spleen)
- diffuse large lymphs
- any age, HIV and transplant, HIV assoc.
- some arise form other B lymphoma
Burkitt
- B cell
- Aggressive; most rapid growing human malignancy
- CD 19, 20, 10 (surface IgM and BCL6)
- t(8;14) MYC aerobic glycolysis
- starry sky (intermediate lymphocytes, abundant mitosis, apoptic bodies)
- usually extra: kidney, ovary, adrenals
- responsive to chemo
African: facial, mandible 100% EBV
HIV: node/extra nodal 25% EBV
Sporadic: all ages, youth-ileocecal mass, kidney, ovaries (1/3) 15-20% EBV
MALT/marginal
- B cell
- Indolent
- CD 19, 20; post germinal center, memory B cells
- t(11;18) BCL10 or MALT1
- H. pyloryi, Sjogren, Thyroiditis
- diffuse lymphs, B cells at diff stages of differentiation including plasma cells
- reactive polyclonal prolif initially → monoclonal transformation (B-cell clone that is still dependent on T cells)
- remain localized for prolonged periods, late systemic spread
- regression may still occur
- may regress w/ antibiotics
Anaplastic Large cell
-T cell
-aggressive; curable w/ chemo
-CD8. CD30
-ALK (2p23) rearrangement- defining
-Soft tissues of children
-Horseshoe shape nucleus
-curable
(immunoperoxidase stain for ALK)
Adult T cell leuk/lymphoma
- T cell
- subacute 1 yr
- CD 4
- Skin, nodes, bone marrow
- convoluted nuclei (clover shaped)
- hypercalcemia (demylination may occur), *peripheral lymphocytosis
-HTLV-1 infection (Japan, w africa, carrib)
Mycosis fungoides
- T cell
- Indolent, years
- CD4 Sezary cell (CLA, CCR4, CCR10)
- starts in skin, RASH patch phase → plaque → tumor → LN → bone marrow
- cerebriform nuclei, *pautrier absc
- topical treatment of “fungus” for years, not curable
Sezary cell leukemia
- T cell
- Aggressive
- CD4 Sezary cell
- Erythroderm (exfoliative) BM: leukemia
- Cerebriform nuclei
HL: Nodular sclerosis type
- most common type
- lacunar and some diagnostic RS cell CD15+, CD30+, *EBV-
- young adults or adolescents
- M=F
- collagenous bands
- mediastinum (cough & dyspnea), lower cervical and supraclavicular nodes
- very good prognosis (stage I or II when diagnosed)
- background infiltrate: T-lymph, eosinophils, macrophages, plasma cells
HL: Mixed cellularity
- mononuclear & diagnostic RS cells CD15+, CD30+, *EBV+
- Biphasic: young adults and older adults 55+
- M > Fe
- poorer prognosis (stage III or IV)
- likely to have B symptoms (*cyclic fever, night sweats, weight loss)
- background infiltrate: T-lymph, eosinophils, macrophages, plasma cells
HL: Lymphocyte predominance
- more common in young males
- frequent L&H (popcorn cell)
- -CD 15-. CD30-. *CD20+. *BCL6+
- cervical/axillary lymphadenopathy, mediastinum
- background: variants of follicular dendritic cells and reactive B cells
- tend to recur
- excellent prognosis
Familial adenomatous polyposis (70% of FAP)
- molecular defect:
- genes:
- transmission:
- sites:
- histology:
-molecular defect: APC/WNT pathway
-genes: APC
-transmission: *autosomal dominant
-sites: none
-histology: NUMEROUS tubular, villous; typical
adeonocarcinoma (need 100 to make diagnosis)
- colorectal carcinoma 100% of untreated pts
- congenital hypertrophy of retinal pigment epi
- numerous colorectal adenomas as teenagers (30yrs)
Familial adenomatous polyposis (<10% of FAP)
- molecular defect:
- genes:
- transmission:
- sites:
- histology:
- molecular defect: DNA mismatch repair
- genes: MUTYH
- transmission: *none, recessive
- sites: none
- histology: sessile serrated adenoma; adenoma; mucinous adenocarcinoma
- colorectal carcinoma 100% of untreated pts
- congenital hypertrophy of retinal pigment epi
- numerous colorectal adenomas as teenagers (<30yrs)
Hereditary nonpolyposis colorectal cancer (Lynch syndrome)
- molecular defect:
- genes:
- transmission:
- sites:
- histology:
- molecular defect: DNA mismatch repair (results in microsatellite instability)
- genes: MSH2, MLH1 (inherit one mutant DNA repair gene)
- transmission: autosomal
- sites: right side
- histology: sessile serrated adenoma; mucinous adenocarcinoma
-increased risk of colorectal & extraintestinal cancer